Mira Pharmaceuticals Shares Data And Research That Positions MIRA1a As A Potential Future Alternative Prescription Medication With Properties Not Found In THC As Well As The Potential For Fewer Side Effects
Portfolio Pulse from Benzinga Newsdesk
Mira Pharmaceuticals has shared data and research that positions its product, MIRA1a, as a potential future alternative prescription medication with properties not found in THC. The company suggests that MIRA1a could have fewer side effects.
September 18, 2023 | 12:36 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Mira Pharmaceuticals' new research suggests its product, MIRA1a, could be a future alternative prescription medication with fewer side effects than THC.
The news is directly related to Mira Pharmaceuticals and its product, MIRA1a. If MIRA1a is indeed a viable alternative to THC with fewer side effects, it could significantly increase the company's market share and revenues, positively impacting its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100